250 related articles for article (PubMed ID: 35600854)
21. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
22. Applications of Chitosan-Alginate-Based Nanoparticles-An Up-to-Date Review.
Niculescu AG; Grumezescu AM
Nanomaterials (Basel); 2022 Jan; 12(2):. PubMed ID: 35055206
[TBL] [Abstract][Full Text] [Related]
23. Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research.
Naskar S; Koutsu K; Sharma S
J Drug Target; 2019 Apr; 27(4):379-393. PubMed ID: 30103626
[TBL] [Abstract][Full Text] [Related]
24. Cell line-dependent cytotoxicity of poly(isobutylcyanoacrylate) nanoparticles coated with chitosan and thiolated chitosan: Insights from cultured human epithelial HeLa, Caco2/TC7 and HT-29/MTX cells.
Pradines B; Lievin-Le Moal V; Vauthier C; Ponchel G; Loiseau PM; Bouchemal K
Int J Pharm; 2015 Aug; 491(1-2):17-20. PubMed ID: 26051544
[TBL] [Abstract][Full Text] [Related]
25. Chitosan based hydrogels and their applications for drug delivery in wound dressings: A review.
Hamedi H; Moradi S; Hudson SM; Tonelli AE
Carbohydr Polym; 2018 Nov; 199():445-460. PubMed ID: 30143150
[TBL] [Abstract][Full Text] [Related]
26. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
[TBL] [Abstract][Full Text] [Related]
27. Anticancer activity of mycobacterial DNA: effect of formulation as chitosan nanoparticles.
Kabbaj M; Phillips NC
J Drug Target; 2001; 9(5):317-28. PubMed ID: 11770702
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and characterization of Fe
Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA
Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
[TBL] [Abstract][Full Text] [Related]
29. Cost-effective alternative to nano-encapsulation: Amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation.
Nguyen MH; Yu H; Kiew TY; Hadinoto K
Eur J Pharm Biopharm; 2015 Oct; 96():1-10. PubMed ID: 26170159
[TBL] [Abstract][Full Text] [Related]
30. Stealth PEGylated chitosan polyelectrolyte complex nanoparticles as drug delivery carrier.
Deng X; Zhao J; Liu K; Wu C; Liang F
J Biomater Sci Polym Ed; 2021 Aug; 32(11):1387-1405. PubMed ID: 33863271
[TBL] [Abstract][Full Text] [Related]
31. Novel chitosan and bacterial cellulose biocomposites tailored with polymeric nanoparticles for modern wound dressing development.
Stanescu PO; Radu IC; Leu Alexa R; Hudita A; Tanasa E; Ghitman J; Stoian O; Tsatsakis A; Ginghina O; Zaharia C; Shtilman M; Mezhuev Y; Galateanu B
Drug Deliv; 2021 Dec; 28(1):1932-1950. PubMed ID: 34550033
[TBL] [Abstract][Full Text] [Related]
32. Versatile carboxymethyl chitin and chitosan nanomaterials: a review.
Narayanan D; Jayakumar R; Chennazhi KP
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(6):574-98. PubMed ID: 25266740
[TBL] [Abstract][Full Text] [Related]
33. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
[TBL] [Abstract][Full Text] [Related]
34. Chitosan-based nanodelivery systems for cancer therapy: Recent advances.
Narmani A; Jafari SM
Carbohydr Polym; 2021 Nov; 272():118464. PubMed ID: 34420724
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of chitosan nano dressing for wound healing: characterization, in vitro and in vivo studies.
Archana D; Dutta J; Dutta PK
Int J Biol Macromol; 2013 Jun; 57():193-203. PubMed ID: 23518244
[TBL] [Abstract][Full Text] [Related]
36. Formulation of nanoparticles ribosome inactivating proteins from Mirabilis jalapa L. (RIP MJ) conjugated AntiEpCAM antibody using low chain chitosan-pectin and cytotoxic activity against breast cancer cell line.
Pertiwi D; Martien R; Sismindari -; Ismail H
Pak J Pharm Sci; 2018 Mar; 31(2):379-384. PubMed ID: 29618424
[TBL] [Abstract][Full Text] [Related]
37. Potential Antimicrobial Applications of Chitosan Nanoparticles (ChNP).
Rozman NAS; Tong WY; Leong CR; Tan WN; Hasanolbasori MA; Abdullah SZ
J Microbiol Biotechnol; 2019 Jul; 29(7):1009-1013. PubMed ID: 31288302
[TBL] [Abstract][Full Text] [Related]
38. Incorporation of ZnO nanoparticles into heparinised polyvinyl alcohol/chitosan hydrogels for wound dressing application.
Khorasani MT; Joorabloo A; Moghaddam A; Shamsi H; MansooriMoghadam Z
Int J Biol Macromol; 2018 Jul; 114():1203-1215. PubMed ID: 29634965
[TBL] [Abstract][Full Text] [Related]
39. Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery.
Ahmed TA; Aljaeid BM
Drug Des Devel Ther; 2016; 10():483-507. PubMed ID: 26869768
[TBL] [Abstract][Full Text] [Related]
40. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
